Matthew Schipper is a Research Associate Professor in the Department of Radiation Oncology with a joint appointment in the department of Biostatistics. He received his Ph.D. in Biostatistics from the University of Michigan in 2006. Prior to joining the Radiation Oncology department he was a Research Investigator in the Department of Radiology at the University of Michigan and a consulting statistician at Innovative Analytics.
Education: Ph.D., Biostatistics, University of Michigan, 2006; M.S., Statistics, Western Michigan University, 2001; B.S., Statistics, Western Michigan University, 2000.
Use of Biomarkers to Individualize and Adapt Treatment; Predictive Risk Modeling; Early Phase Oncology Study Design.
Presner JR, Zhao S, Erho N, Schipper MJ, Iyer MK, Dhanasekaran SM, Magi-Galluzzi C, Karnes J, Mehra R, Sahu A, Davicioni E, Den RB, Dicker AP, Klein E, Jenkins RB, Chinnaiyan AM, Feng FY: RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1. Lancet Oncology 15(13): 1469-80, 2014.
Anna E. Arthur; Karen E. Peterson; Jincheng Shen; Zora Djuric; Jeremy M. G. Taylor; James R. Hebert; Sonia A. Duffy; Lisa A. Peterson; Emily L. Bellile; Joel R. Whitfield; et al. Diet and proinflammatory cytokine levels in head and neck squamous cell carcinoma. Cancer. 2014;120(17):2704-2712.
Yuni K. Dewaraja; Matthew J. Schipper; Jincheng Shen; Lauren B. Smith; Jure Murgic; Hatice Savas; Ehab Youssef; Denise Regan; Scott J. Wilderman; Peter L. Roberson; et al. Tumor-absorbed dose predicts progression-free survival following 131I-tositumomab radioimmunotherapy. Journal of Nuclear Medicine. 2014;55(7):1047-1053.